Glucose Viaflo Baxter

Glucose Viaflo Baxter is an intravenous solution for injection that contains the active ingredient glucose. The product is supplied in a sterile liquid form, with strength not specified, and is marketed in the EU. It is classified as an excipient/solvent and is prescribed (Rx) for clinical situations that require rapid carbohydrate provision and fluid replacement. Use is limited to medical supervision by qualified healthcare providers.

Glucose Viaflo Baxter is used in several clinical contexts where rapid elevation of blood glucose or fluid volume is needed.

- Treatment of hypoglycemia to quickly raise blood glucose levels - Fluid replacement in patients with dehydration or blood loss - Source of carbohydrate in parenteral nutrition regimens - Intra‑operative management to maintain glucose homeostasis - Support of electrolyte balance when combined with compatible IV solutions

When administered intravenously, Glucose Viaflo Baxter may be associated with a range of observed effects.

Common: - Mild, transient hyperglycemia - Local irritation or discomfort at the injection site - Nausea or headache during infusion

Serious: - Severe hyperglycemia requiring medical intervention - Anaphylactic or severe allergic reaction - Cardiac arrhythmia related to rapid glucose shifts - Pulmonary edema from fluid overload - Significant electrolyte disturbances - Unexpected hypoglycemia after abrupt infusion cessation

Healthcare professionals should consider several precautions before prescribing Glucose Viaflo Baxter.

- Verify baseline blood glucose and adjust infusion accordingly - Assess patient fluid status and cardiac function prior to administration - Monitor electrolytes, especially potassium and sodium, during therapy - Adjust infusion rate in patients with renal impairment - Avoid rapid large‑volume infusions unless clinically indicated - Employ strict aseptic technique to prevent catheter‑related infections - Consider unknown pregnancy category and weigh risks versus benefits

Glucose Viaflo Baxter can interact with other agents; awareness of potential interactions helps maintain safety.

Avoid: - Concurrent insulin therapy without dose adjustment, which may precipitate hypoglycemia - Co‑administration with other hypertonic dextrose solutions that could cause excessive glucose load

Use with caution: - Diuretics that alter fluid and electrolyte balance - Beta‑blockers that may mask hypoglycemia symptoms - Corticosteroids that can increase blood glucose levels - Sodium‑containing IV solutions that may contribute to fluid overload - Medications influencing potassium levels, such as ACE inhibitors